This article documents evidence-based pharmacologic interventions to promote successful smoking cessation among employees who smoke. The article also highlights supporting evidence for the use of pharmacologic agents to treat tobacco dependence and can guide successful, personalized, pharmacologic smoking cessation interventions in occupational clinical practice. Prescribing clinicians will also find information about the latest research and development of medications to promote smoking cessation, including recently implemented black box warnings by the U.S. Food and Drug Administration.
References
1.
BarbeauE. M.CalderonP.HartmanC.QuinnM.MarkkanenP.RoelofsC. (2006). Results of a union-based smoking cessation intervention for apprentice iron workers (United States). Cancer Causes and Control, 17, 53–61.
2.
BealsJ. K. (2010). Using the genetics of smoking behavior to optimize selection of cessation technique. Genomics in Practice. Retrieved from www.medscape.com/viewarticle/723909
BravermanM. T.AaroL. E., & HetlandJ. (2007). Changes in smoking among restaurant and bar employees following Norway's comprehensive smoking ban. Health Promotion International, 23(1), 5–15.
5.
CahillK.MoherM., & LancasterT. (2008). Workplace interventions for smoking cessation. Cochrane Database of Systematic Reviews, 4, 16.
6.
Centers for Disease Control and Prevention. (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 2000–2004. Morbidity and Mortality Weekly Report, 57(45), 1226–1228. Retrieved from www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm
7.
ConroyM. B.MajchrzakN. E.ReganS.SilvermanC. B.SchneiderL. I., & RigottiN. A. (2005). The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care. Nicotine & Tobacco Research, 7(Suppl. 1), S29–S34.
8.
EmmonsK. M.LinnanL. A.ShadelW. G.MarcusB., & AbramsD. B. (1999). The working healthy project: A worksite health-promotion trial targeting physical activity, diet, and smoking. Journal of Occupational and Environmental Medicine, 41(7), 545–555.
9.
Institute for Clinical Systems Improvement. (2008). Preventive services for adults. Bloomington, MT: National Guidelines Clearinghouse.
10.
KadowakiT.OkamuraT.FunakoshiT.OkayamaA.KandaH.MiyamatsuN. (2004). Effectiveness of annual interventions for smoking cessation in an occupational setting in Japan. Environmental Health and Preventive Medicine, 9, 161–164.
KroonL. A. (2007). Drug interactions with smoking. American Journal of Health-System Pharmacy, 64(18), 1917–1921. Retrieved from www.medscape.com/viewarticle/562754
13.
LermanC., & BerrettiniW. (2003). Elucidating the role of genetic factors in smoking behavior and nicotine dependence. American Journal of Medical Genetics Neuropsychiatric Genetics, 118(1), 48–54.
National Institute for Health and Clinical Excellence. (2007a). Varenicline for smoking cessation. London: National Guidelines Clearinghouse.
19.
National Institute for Health and Clinical Excellence. (2007b). Workplace health promotion: How to help employees stop smoking. London: National Guidelines Clearinghouse.
20.
National Institute for Health and Clinical Excellence. (2008). Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities. London: National Guidelines Clearinghouse.
21.
Registered Nurses Association of Ontario. (2007). Integrating smoking cessation into daily nursing practice. Toronto, Ontario, Canada: National Guidelines Clearinghouse.
22.
Rodriguez-ArtalejoF.UrdinguioLafuente P.Guallar-CastillónP.DeblangGarteizaurrekoa P.MartínezSáinz O.AzcárateDíez J. I. (2003). One year effectiveness of an individualized smoking cessation intervention at the workplace: A randomized controlled trial. Occupational and Environmental Medicine, 60. 358–363.
23.
RovinaN.NikoloutsouI.KatsaniG.DimaE.FransisK.RoussosC. (2010). Effectiveness of pharmacotherapy and behavioral interventions in smoking cessation in actual clinical practice. Therapeutic Advances in Respiratory Disease, 3(6). 279–287. Retrieved from www.medscape.com/viewarticle/714431
24.
SmedslundG.FisherK. J.BolesS. M., & LichtensteinE. (2004). The effectiveness of workplace smoking cessation programmes: A meta-analysis of recent studies. Tobacco Control, 13, 197–204.
25.
StantonW. R.LoweJ. B.MoffattJ., & Del MarC. B. (2004). Randomised control trial of a smoking cessation intervention directed at men whose partners are pregnant. Preventive Medicine, 38, 6–9.
U.S. Department of Health and Human Services, Public Health Service. (2008). Treating tobacco use and dependence: 2008 update. Rock-ville, MD: National Guidelines Clearinghouse.
30.
U.S. Preventive Services Task Force. (2009). Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Annals of Internal Medicine, 150(8), 551–555.
31.
ZevinS., & BenowitzN. L. (1999). Drug interactions with tobacco smoking: An update. Clinical Pharmacokinetics, 36, 425–438.
